Skip to main content
. 2013 Jul 23;2013(7):CD006407. doi: 10.1002/14651858.CD006407.pub2

Comparison 1. MSD‐HSCT versus IST ‐ all patients.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Mortality 3 229 Hazard Ratio (Random, 95% CI) 0.95 [0.43, 2.12]
2 Secondary clonal disease or malignancies 2 170 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.54 [0.07, 4.00]